Home / Auditor changes / Stoke Therapeutics, Inc.
Filed 2026-03-27 路 Form 8-K 路 Accession 0001193125-26-129168 mid
Price before filing: $33.7 (2026-03-26 close, split/dividend-adjusted)
Market cap at flag: $2.07B (2026-03-27) 路 Latest: $1.60B (2026-10-16)
| Window | STOK | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +0.0% | +10.9% | -10.8% | 2026-04-27 |
| 90 days | -9.8% | +14.1% | -23.9% | 2026-06-25 |
| 180 days | -22.5% | +19.6% | -42.2% | 2026-09-23 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 7 insiders sold $3.1M (27 sales)
30 days after: 1 insider sold $60K (1 sale)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-02 | Krainer Adrian R. Director | Sale | 7,229 | $39.66 | $287K | yes | Form 4 |
| 2026-03-10 | Krainer Adrian R. Director | Sale | 33,243 | $39.74 | $1.3M | yes | Form 4 |
| 2026-03-10 | TZIANABOS ARTHUR Interim Executive Chair, Director | Sale | 4,355 | $40.00 | $174K | yes | Form 4 |
| 2026-03-13 | LEVIN ARTHUR A Director | Sale | 605 | $36.80 | $22K | yes | Form 4 |
| 2026-03-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 2,476 | $32.74 | $81K | no | Form 4 |
| 2026-03-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 1,791 | $33.38 | $60K | no | Form 4 |
| 2026-03-17 | Hoitt Jason Chief Patient Officer | Sale | 1,033 | $32.74 | $34K | no | Form 4 |
| 2026-03-17 | Hoitt Jason Chief Patient Officer | Sale | 748 | $33.38 | $25K | no | Form 4 |
| 2026-03-17 | Leggett Thomas Chief Financial Officer | Sale | 1,274 | $32.74 | $42K | no | Form 4 |
| 2026-03-17 | Leggett Thomas Chief Financial Officer | Sale | 922 | $33.38 | $31K | no | Form 4 |
| 2026-03-17 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 3,577 | $32.74 | $117K | yes | Form 4 |
| 2026-03-17 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 2,587 | $33.38 | $86K | yes | Form 4 |
| 2026-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 4,222 | $31.28 | $132K | no | Form 4 |
| 2026-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 334 | $31.79 | $11K | no | Form 4 |
| 2026-03-18 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 72 | $32.85 | $2K | no | Form 4 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | 1,762 | $31.28 | $55K | no | Form 4 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | 139 | $31.79 | $4K | no | Form 4 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | 30 | $32.85 | $986 | no | Form 4 |
| 2026-03-18 | Leggett Thomas Chief Financial Officer | Sale | 2,173 | $31.28 | $68K | no | Form 4 |
| 2026-03-18 | Leggett Thomas Chief Financial Officer | Sale | 172 | $31.79 | $5K | no | Form 4 |
| 2026-03-18 | Leggett Thomas Chief Financial Officer | Sale | 37 | $32.85 | $1K | no | Form 4 |
| 2026-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 6,100 | $31.28 | $191K | yes | Form 4 |
| 2026-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 483 | $31.79 | $15K | yes | Form 4 |
| 2026-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 103 | $32.85 | $3K | yes | Form 4 |
| 2026-03-19 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 1,461 | $29.99 | $44K | yes | Form 4 |
| 2026-03-27: red flag filed | |||||||
Showing 25 of 28 transactions.
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-12-27 to 2026-04-26. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"(the "Company") dismissed KPMG LLP ("KPMG") as the Company's independent registered public accounting firm."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: dismissed
Disagreements reported: no
Former auditor: KPMG LLP · New auditor: Ernst & Young LLP
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.